Literature DB >> 30191004

Surveillance for hepatocellular carcinoma in chronic hepatitis B virus infection: for whom.

Jihyun An1, Han Chu Lee1.   

Abstract

Entities:  

Keywords:  chronic hepatitis B; hepatocellular carcinoma; risk prediction; surveillance

Year:  2015        PMID： 30191004      PMCID： PMC6095305          DOI： 10.2217/hep.15.17

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  26 in total

1.  Identifying hepatitis B carriers at low risk for hepatocellular carcinoma.

Authors:  Henry Lik-Yuen Chan
Journal:  Gastroenterology       Date:  2012-03-23       Impact factor: 22.682

2.  Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.

Authors:  Man-Fung Yuen; Yasuhito Tanaka; Daniel Yee-Tak Fong; James Fung; Danny Ka-Ho Wong; John Chi-Hang Yuen; David Yiu-Kuen But; Annie On-On Chan; Benjamin Chun-Yu Wong; Masashi Mizokami; Ching-Lung Lai
Journal:  J Hepatol       Date:  2008-09-21       Impact factor: 25.083

3.  Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Authors:  Hwai-I Yang; Morris Sherman; Jun Su; Pei-Jer Chen; Yun-Fan Liaw; Uchenna H Iloeje; Chien-Jen Chen
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

4.  Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.

Authors:  Ju-Yeon Cho; Yong-Han Paik; Won Sohn; Hyun Chin Cho; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Gut       Date:  2014-03-10       Impact factor: 23.059

5.  Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.

Authors:  Gi-Ae Kim; Han Chu Lee; Min-Ju Kim; Yeonjung Ha; Eui Ju Park; Jihyun An; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim
Journal:  J Hepatol       Date:  2014-11-28       Impact factor: 25.083

6.  Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

Authors:  Vincent Wai-Sun Wong; Stephen Lam Chan; Frankie Mo; Tung-Ching Chan; Herbert Ho-Fung Loong; Grace Lai-Hung Wong; Yanni Yan-Ni Lui; Anthony Tak-Cheung Chan; Joseph Jao-Yiu Sung; Winnie Yeo; Henry Lik-Yuen Chan; Tony Shu-Kam Mok
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

7.  Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.

Authors:  Grace Lai-Hung Wong; Henry Lik-Yuen Chan; Christy Wing-Hin Mak; Stanley King-Yeung Lee; Zoe Man-Yi Ip; Andrew Ting-Ho Lam; Henry Wing-Hang Iu; Joyce May-Sum Leung; Jennifer Wing-Yan Lai; Angeline Oi-Shan Lo; Hoi-Yun Chan; Vincent Wai-Sun Wong
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

8.  Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.

Authors:  Young-Suk Lim; Seungbong Han; Nae-Yun Heo; Ju Hyun Shim; Han Chu Lee; Dong Jin Suh
Journal:  Gastroenterology       Date:  2014-02-25       Impact factor: 22.682

9.  A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

Authors:  J P Villeneuve; M Desrochers; C Infante-Rivard; B Willems; G Raymond; M Bourcier; J Côté; G Richer
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.